Ginseng Extracts: Preclinical Evaluation in the Treatment of Seizures
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 08/27/2019
Pipeline Type
Dietary Supplements
Phase Of Development
Preclinical
Sponsors and Collaborators
Baylor College of Medicine, NIH-NINDS (NS39941), Epilepsy Foundation (EF)
Mechanism of Action
Mechanism Description
possibly slows or block syncronization or speed of spread of focal discharges
Populations Tested In
N/A
Other Resources
Special FDA Designation
Nonprofit or Government Support
Nonprofit
Nonprofit or Government Support Description
Epilepsy Foundation -NTCG 2005
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
No presentations found. Published Epilepsia46(1): 15-22, 2005
Location of Clinical Trials
Baylor College of Medicine
Clinical Trial link